Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / SDC1

SDC1

Basics

Aliases:
This biomarker is also known as:
  • syndecan proteoglycan 1,
  • SDC,
  • CD138 antigen,
  • syndecan,
  • P18827,
  • syndecan-1,
  • CD138,
  • syndecan 1,
  • heparan sulfate proteoglycan fibroblast growth factor receptor,

View in BioMuta

Description…

SDC1 is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins.

Attributes

QA State: Curated
Type: Protein
Short Name:
HGNC Name: SDC1

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Ovary

Attributes

Phase: Two
QA State: Under Review

Overview

SDC1 was shown to localize to vascular-like structures in ovarian cancer but not in normal ovaries.

Performance Comment

SDC1 was one of 13 genes out of 50 selected for further validation in PMID:21617380.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement